-
Mashup Score: 1Progress in Geriatric Oncology: Reviewing the ASCO Guideline - 6 month(s) ago
Home > Progress in Geriatric Oncology: Reviewing the ASCO Guideline Dr. Chadi Nabhan sits down with 3 experts from the Cancer and Aging Research Group who contributed to the American Society of Clinical Oncology guideline on the practical assessment and management of age-associated vulnerabilities in older patients receiving systemic cancer therapy: William Dale, MD, PhD, FASCO, of the City of Hope Comprehensive Cancer Center; Supriya Mohile, MD, MS, of the University of Rochester; and Heidi Klepin, MD,
Source: docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 1Collection Details : Oncology Times - 7 month(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Large randomized clinical trials could lead to unintentional bias because of an imbalance of assigned treatment discontinuations between experimental and control arms, according to Faris Tamimi, MD, at @pmcancercentre. Listen to the podcast here: https://t.co/OpGw1SC2s8 #ASCO https://t.co/V1mXMyS7SD
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Immunotherapy-based regimens for patients with sarcomatoid and rhabdoid metastatic non-clear cell #RenalCellCarcinoma demonstrated significantly improved survival and response rates compared to VEGF-targeted therapy. Read more about the #research: https://t.co/N9ls5lAdqN #ASCO https://t.co/ROufH5c7Pb
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients with sarcomatoid and/or rhabdoid metastatic non-clear cell renal cell carcinoma are known to have poor clinical outcomes. Studies found potential benefits of immunotherapy-based regimens for this patient population: https://t.co/36Ffv4hNfm #RenalCancer #Carcinoma #ASCO https://t.co/m64AjfhW3z
-
-
Mashup Score: 12023 ASCO Direct Philadelphia | Total Health - 7 month(s) ago
This meeting will showcase abstracts from highly-rated ASCO 2023 presentations, breaking down the key takeaways to directly impact patient care. Attendees will engage in real-time with the experts presenting and colleagues local to Pennsylvania.
Source: www.totalhealthoncology.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
An updated guideline and panel recommends treatment with sacituzumab govitecan for patients with HR-positive/HER2-negative metastatic breast cancer who are refractory to endocrine therapy.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Using Measurable Residual Disease to Optimize Management of AML, ALL, and Chronic Myeloid Leukemia - 8 month(s) ago
In this review, we discuss the use of measurable residual disease (MRD) in AML, ALL, and chronic myeloid leukemia (CML). Our aims were to review the different methodologies for MRD assessment; describe the clinical relevance and medical decision making on the basis of MRD; compare and contrast the usage of MRD across AML, ALL, and CML; and discuss what patients need to know about MRD as it relates to their disease status and treatment. Finally, we discuss ongoing challenges and future directions with the goal of optimizing MRD usage in leukemia management.
Source: ascopubs.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 8
CarouselUncategorized New 2023 ASCO Geriatric Oncology Updated Guidelines: Practical Geriatric Assessment and Other Resources July 10, 2023July 17, 2023 Rolando Mantilla Welcome to CARG! The mission of the Cancer and Aging Research Group is to join geriatric oncology…
Source: www.mycarg.orgCategories: Hem/Oncs, Latest HeadlinesTweet
@chadinabhan sits down with 3 experts from the Cancer and Aging Research Group who contributed to the American Society of Clinical Oncology to discuss vulnerabilities in older patients receiving systemic cancer therapy. #cancertherapy #ASCO https://t.co/y5WqVEuU6g https://t.co/aKcfYFOqCP